ZINPLAVA 25 mg/mL (Bezlotoxumab INJECTION, SOLUTION) 25 mg/mL

ZINPLAVA 25 mg/mL is an intravenous solution containing bezlotoxumab, used to manage certain infections. This single-dose injection is designed for specific medical conditions and is manufactured by Merck Sharp & Dohme LLC.

Strength

25 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3025-00) / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZINPLAVA 25 mg/mL is primarily used to manage infections caused by Clostridioides difficile. This medication is administered intravenously and is intended for specific therapeutic uses as determined by healthcare professionals. The primary use of bezlotoxumab is to reduce the risk of recurrence of these infections.

Side Effects

Common effects of ZINPLAVA 25 mg/mL may include reactions at the injection site, such as redness or swelling. Some individuals might experience headaches or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

ZINPLAVA 25 mg/mL should be handled with care, ensuring proper storage and administration protocols are followed. It is important to inform healthcare providers about any allergies or pre-existing conditions before use. This medication is for intravenous use only and should be administered by trained professionals.

Avoid Interactions

ZINPLAVA 25 mg/mL may interact with other medications, particularly those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of this medication.

Frequently Asked Questions

ZINPLAVA 25 mg/mL is used to manage infections caused by Clostridioides difficile, particularly to reduce the risk of recurrence.

ZINPLAVA 25 mg/mL is administered intravenously by healthcare professionals.

Common effects may include reactions at the injection site, headaches, and fatigue.

Potential interactions with other medications should be discussed with a healthcare provider.

Proper storage, administration by trained professionals, and informing healthcare providers about allergies or pre-existing conditions are important precautions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.